Japan Breast Cancer Market Analysis


  • Type: Oncology area
  • Published : April 2021
  • Region: Asia
  • Country: Japan
  • Report ID : 3525

  • Format: PPT, PDF

Japan Breast Cancer Therapeutics Market: Segmented by Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy and Immunotherapy) and Distribution Channel (Online pharmacies, Hospital Pharmacies and Retail Pharmacies) – Growth, Trends and Forecasts (2019 – 2028)


The Japan Breast Cancer Therapeutics Market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 9.6% during the forecast period

The major factors that drive the market include the high prevalence of breast cancer and awareness programs by government and private organizations. According to the National Cancer Centre of Japan, breast cancer is the most common cancer in women. About 89,100 cases were reported in the country in 2017. Also, breast cancer is the 5th largest cause of mortality in Japan. About 14,400 casualties were reported in 2017. The increasing incidences enable the growth of the screening rates thus also allowing the growth of the market in this region. The ‘Pink Ribbon Festival’ initiated by the Japan Cancer Society enables to raise public awareness of the importance of early detection, diagnosis and treatment of breast cancer.

Market Drivers

One of the foremost drivers influencing the growth of the global market is the increased prevalence of breast cancer across the country, which is expected to result in a large patient population demanding accurate and efficient treatment options. Breast cancer is one of the most prevalent forms of cancer and improved diagnostics are further expected to result in a greater number of patients being diagnosed.

Furthermore, the increasing demand for preventive care and early treatment has led many individuals to undergo cancer screening tests, which would also strongly drive the number of patients demanding treatment in the forecast period. Besides, the increasing patient awareness due to such alarming statistics is anticipated to further drive the market growth. Hence, the rising prevalence of breast cancer is projected to boost the market growth in the forecast period.

One of the critical factors that are expected to strongly propel the market growth in the forthcoming years is new product launches for the treatment of breast cancer by key players. These product launches are projected to positively impact the market as they are technologically advanced and may often result in better treatment outcomes for patients.

Additionally, some of the new product launches are specifically aimed at the treatment of breast cancer that was previously untreatable, or the earlier treatments were not successful in terms of improved outcomes for patients. Therefore, these factors are projected to positively impact the market during the forecast period.

1. Japan Breast Cancer Therapeutics Market Overview………………………………….
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. High prevalence of breast cancer and awareness programs by government and private organizations
B. Large patient population demanding accurate and efficient treatment options
C. Increasing demand for preventive care and early treatment
3. Major Breast Cancer Types …………………………………………………….
A. Invasive breast cancer
I. Invasive ductal carcinoma
II. Invasive lobular carcinoma
B. Non-invasive (in situ) breast cancer
I. Ductal carcinoma in situ (DCIS)
II. Lobular carcinoma in situ (LCIS)
4. Breast Cancer Therapeutics Market Segmentation…………………………………….
A. Therapy
I. Targeted Therapy
II. Hormonal Therapy
III. Chemotherapy
IV. Immunotherapy
B. Distribution Channel
I. Online pharmacies
II. Hospital Pharmacies
III. Retail Pharmacies
5. Breast Cancer Major Drugs Market Share……………………………………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. AstraZeneca Company overview, Product & Services, Strategies & Financials
B. Roche Diagnostics Company overview, Product & Services, Strategies & Financials
C. Pfizer Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………….
A. New Trends and Development of Breast Cancer Therapeutics market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Therapy:

Therapies used for treating breast cancer are Targeted Therapy, Hormonal Therapy, Chemotherapy and Immunotherapy. Targeted Therapy is further classified into Abemaciclib, Ado-Trastuzumab Emtansine, Everolimus, Trastuzumab, Ribociclib, Palbociclib, Pertuzumab and Olaparib. Hormonal Therapy is further classified into Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors and Estrogen Receptor Downregulators (ERDs).

The targeted therapy segment held a dominant share of the market in 2019. The dominance is owing to the greater adoption of this therapy. The hormonal therapy segment is anticipated to register a lower market share in the forecast period. This is primarily attributable to the increasing availability of generic equivalents of hormonal therapy drugs. Similarly, the chemotherapy segment is anticipated to register a lower growth rate and share due to the increasing influx of generic equivalents. The immunotherapy segment is set to register a higher growth rate.

By Distribution Channel:

By Distribution Channel, the market is segmented into Online pharmacies, Hospital Pharmacies and Retail Pharmacies.

Top 5 Major Players

Some of the major players in the market are AstraZeneca, Roche Diagnostics, Pfizer, Novartis and Baxter. These companies account for the dominant share of the market due to their strong and robust product portfolios of drugs for breast cancer treatment. Furthermore, these companies are engaged in cutting edge R&D for the development of pharmaceuticals for the treatment of breast cancer. Their various strategic executions are expected to contribute to their efforts in the expansion of their market revenue in the forecast period.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements